Cargando…

Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study

INTRODUCTION: Central precocious puberty (CPP) results from premature activation of hypothalamic-pituitary-gonadal axis, with the consequent increase of gonadotropin-releasing hormone (GnRH); GnRH agonists (GnRHa) represent the gold-standard therapy in children with CPP although their use might be r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valenzise, M., Nasso, C., Scarfone, A., Rottura, M., Cafarella, G., Pallio, G., Visalli, G., Di Prima, E., Nasso, E., Squadrito, V., Wasniewska, M., Irrera, P., Arcoraci, V., Squadrito, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229807/ https://www.ncbi.nlm.nih.gov/pubmed/37266535 http://dx.doi.org/10.3389/fped.2023.1170025

Ejemplares similares

Appropriateness of Antibiotic Prescribing in Hospitalized Children: A Focus on the Real-World Scenario of the Different Paediatric Subspecialties
por: Nasso, Chiara, et al.
Publicado: (2022)

A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily
por: Nasso, Chiara, et al.
Publicado: (2020)

The effect of triptorelin and leuprolide on the level of sex hormones in girls with central precocious puberty and its clinical efficacy analysis
por: Wang, Lan, et al.
Publicado: (2021)

Central Precocious Puberty: Treatment with Triptorelin 11.25 mg
por: Chiocca, Elena, et al.
Publicado: (2012)

Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2021)

Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty
por: Omar, Anjumanara Anver, et al.
Publicado: (2020)

Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register
por: Arcoraci, Vincenzo, et al.
Publicado: (2022)

Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty
por: Ahn, Jungmin, et al.
Publicado: (2023)

Pharmacological Treatment of Diabetic and Non-Diabetic Patients With Coronary Artery Disease in the Real World of General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2022)

Evaluation of Hypersensitivity Reactions with Leuprolide Acetate and Triptorelin Acetate in Children
por: Metbulut, Azize Pınar, et al.
Publicado: (2021)

Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
por: Neely, E. Kirk, et al.
Publicado: (2010)

6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children With Central Precocious Puberty
por: Eugster, Erica A, et al.
Publicado: (2021)

Triptorelin stimulated luteinizing hormone concentrations for diagnosing central precocious puberty: study of diagnostic accuracy
por: Vukovic, Rade, et al.
Publicado: (2021)

Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study
por: Pallio, Giovanni, et al.
Publicado: (2020)

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
por: Vurallı, Doğuş, et al.
Publicado: (2020)

SUN-063 Usefulness of a LHRH Test with Low Dose of Triptorelin Pamoate in the Diagnosis of Precocious Puberty in Girls
por: Llano, Juan Pablo, et al.
Publicado: (2020)

β-Caryophyllene Inhibits Cell Proliferation through a Direct Modulation of CB2 Receptors in Glioblastoma Cells
por: Irrera, Natasha, et al.
Publicado: (2020)

Targeting Adenosine Receptor by Polydeoxyribonucleotide: An Effective Therapeutic Strategy to Induce White-to-Brown Adipose Differentiation and to Curb Obesity
por: Mannino, Federica, et al.
Publicado: (2021)

Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
por: Wiromrat, Pattara, et al.
Publicado: (2019)

Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study
por: Klein, Karen O, et al.
Publicado: (2023)

PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation
por: Irrera, Natasha, et al.
Publicado: (2020)

Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty
por: Yoo, Eunjoo, et al.
Publicado: (2023)

Effect of triptorelin 3.75 mg subcutaneously injection every 6 weeks on adult height in girls with idiopathic central precocious puberty
por: Liang, Yan, et al.
Publicado: (2015)

Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing
por: Galeano, Mariarosaria, et al.
Publicado: (2021)

Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study
por: Lee, Peter A, et al.
Publicado: (2011)

Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients
por: Arcoraci, Vincenzo, et al.
Publicado: (2021)

Oxidative Stress: Harms and Benefits for Human Health
por: Pizzino, Gabriele, et al.
Publicado: (2017)

Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions
por: Barbieri, Maria Antonietta, et al.
Publicado: (2020)

Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty
por: Klein, Karen O, et al.
Publicado: (2020)

Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review
por: Lauro, Rita, et al.
Publicado: (2021)

A Rare Case of Precocious Puberty in a Child with a Novel GATA-4 Gene Mutation: Implications for Disorders of Sex Development (DSD) and Review of the Literature
por: Aversa, Tommaso, et al.
Publicado: (2023)

Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis
por: D’Ascola, Angela, et al.
Publicado: (2019)

Corrigendum: Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis
por: D’Ascola, Angela, et al.
Publicado: (2022)

Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty
por: Kim, You Jin, et al.
Publicado: (2013)

Beneficial Effects of Polydeoxyribonucleotide (PDRN) in an In Vitro Model of Fuchs Endothelial Corneal Dystrophy
por: Ceravolo, Ida, et al.
Publicado: (2022)

Peculiarities of Precocious Puberty in Boys and Girls With McCune-Albright Syndrome
por: Corica, Domenico, et al.
Publicado: (2018)

Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center
por: Chung, Lindsey Yoojin, et al.
Publicado: (2021)

ODP397 Small-volume, Subcutaneous, 6-month Leuprolide Acetate Effectively Reduces Growth Velocity to Prepubertal Levels in Children with Central Precocious Puberty
por: Klein, Karen O, et al.
Publicado: (2022)

Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways
por: Procopio, Maria Cristina, et al.
Publicado: (2021)

Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study
por: Luo, Xiaoping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j2temdqliai36c515nk8dkdahu